Literature DB >> 6586859

Histologic changes in the skin of the rhino mouse (hrrhhrrh) induced by retinoids.

R E Ashton, M J Connor, N J Lowe.   

Abstract

The effects of four retinoids, all-trans-retinoic acid (RA), 13-cis-retinoic acid (13-cis-RA), aromatic retinoid, and arotinoid ethyl ester ( arotinoid ) were examined on the skin of the rhino mouse. Rhino mouse skin is characterized by the presence of keratin-containing utricles attached to the epidermis, and subcutaneous cysts, both of which are derived from hair follicles. The utricles were examined in horizontal sheets of epidermis, and in vertical histologic sections. After applications of 0.1 ml of 0.1% RA, 0.1% 13-cis-RA, 0.1% aromatic retinoid, or 0.001% arotinoid in acetone to the dorsal skin for 5 days a week for 2 weeks, there was a reduction of utricle diameter to 45%, 52%, 30%, and 31% of acetone-treated controls, respectively. Histologic examination of the epidermis revealed that a dose-dependent hyperplasia and thickening of the epidermis and the stratum granulosum was induced by the retinoids when given at subtoxic doses, being most marked after arotinoid or RA. The thickness of the walls of the utricles also increased with increasing dose of retinoid, paralleling the changes in the epidermis. After doses of 0.1% RA and 0.001% arotinoid , the utricles resembled the hair follicles of hairless mice. Hyperplasia of the epidermis appears to be a primary effect of retinoids or rhino mouse skin. Hyperproliferation of the utricle wall is accompanied by a reduction in the size of the utricle lumen, preceding eventual differentiation of the utricles to normal-looking pilar units.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6586859     DOI: 10.1111/1523-1747.ep12261472

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  The rhino mouse model: the effects of topically applied all-trans retinoic acid and CD271 on the fine structure of the epidermis and utricle wall of pseudocomedones.

Authors:  F Bernerd; J P Ortonne; M Bouclier; A Chatelus; C Hensby
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Evaluation of retinoids as therapeutic agents in dermatology.

Authors:  A H Lewin; M E Bos; F C Zusi; X Nair; G Whiting; P Bouquin; G Tetrault; F I Carroll
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

3.  Separation of retinoid-induced epidermal and dermal thickening from skin irritation.

Authors:  James Varani; Helene Fligiel; Jian Zhang; Muhammad Nadeem Aslam; Yi Lu; Lindsay A Dehne; Evan T Keller
Journal:  Arch Dermatol Res       Date:  2003-10-16       Impact factor: 3.017

4.  Topical tazarotene for the treatment of ectropion in ichthyosis.

Authors:  Brittany G Craiglow; Keith A Choate; Leonard M Milstone
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

5.  Retinoic acid provokes a regeneration-like proliferative response in murine epidermis. A bivariate DNA/bromodeoxyuridine flow cytometric study.

Authors:  C Lützow-Holm; P De Angelis; O P Clausen
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

6.  Effect of topical application of 13-cis retinoic acid on skin of hairless rats and hairless mice.

Authors:  S M Puhvel; M Sakamoto
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

Review 7.  Human in vivo pharmacology of topical retinoids.

Authors:  C E Griffiths; J J Voorhees
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

8.  Evaluation of topical retinoids for cutaneous pharmacological activity in Yucatan microswine.

Authors:  G J Gendimenico; F T Liebel; J A Fernandez; J A Mezick
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

9.  Gene expression of retinoic acid receptors and cellular retinoic acid-binding proteins in rhino and hairless mouse skin.

Authors:  B C Beehler; S Chen; K M Tramposch
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 10.  Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders.

Authors:  Joachim G S Veit; Valérie De Glas; Benoît Balau; Haoming Liu; Florence Bourlond; Amy S Paller; Yves Poumay; Philippe Diaz
Journal:  J Invest Dermatol       Date:  2020-06-04       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.